Search

Subject Alendronate -- Menopause -- Prediabetic

1. Alendronate improves fasting plasma glucose and insulin sensitivity, and decreases insulin resistance in prediabetic osteopenic postmenopausal women: A randomized triple‐blind clinical trial. Issue 3 (23rd October 2018)

Authors:
Karimi Fard, Maryam; Aminorroaya, Ashraf; Kachuei, Ali; Salamat, Mohammad Reza; Hadi Alijanvand, Moluk; Aminorroaya Yamini, Sima; Karimifar, Mansoor; Feizi, Awat; Amini, Massoud
Journal:
Journal of diabetes investigation
Issue:
Volume 10:Issue 3(2019)
Page Start:
731
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search

  • Alendronate -- Menopause -- Prediabetic 1